Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses

NCT00360737 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Emergent BioSolutions

Collaborators